Short answer
Olema Pharmaceuticals, Inc. (OLMA) filed an 8-K current report with the SEC on August 13, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Jason O’Byrne appointed CFO, principal financial officer and principal accounting officer effective August 11, 2026.
Olema Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Jason O’Byrne appointed CFO, principal financial officer and principal accounting officer effective August 11, 2026
- Senior biopharma finance executive with prior CFO roles at Vir Biotechnology and Caribou Biosciences
- Base salary $545,000 plus 45% target annual bonus and $350,000 sign-on bonus
- Inducement option for 650,000 shares, vesting over four years with 25% vesting after one year
- Severance includes 12 months’ salary, prorated bonus and equity acceleration, with enhanced Change in Control protections
Item 7.01 · Regulation FD Disclosure
- CFO appointment disclosed under Regulation FD, making the leadership change broadly available to investors
- Mr. O’Byrne appointed Chief Financial Officer, adding new executive oversight of finance and reporting
- Leadership transition may affect financial strategy, capital planning, and investor communications
Item EX-99.1 · Exhibit EX-99.1
- Jason O’Byrne appointed CFO, succeeding prior finance leadership as Olema approaches pivotal OPERA-01 data
- Executive brings IPO, capital markets, acquisition integration, and commercial-stage biotechnology experience
- Appointment supports potential palazestrant launch and transition toward a fully integrated oncology company
- Near-term investor focus: OPERA-01 Phase 3 data, palazestrant launch readiness, and capital allocation under new CFO നേതൃത്വ
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Olema Pharmaceuticals, Inc. 8-K filings
Get the next OLMA 8-K as it lands
Follow OLMA for push alerts, or ask the research agent what this filing means.